Alto Neuroscience (ANRO) PT Raised to $41 at Baird

March 18, 2026 7:43 AM

Baird analyst Brian Skorney raised the price target on Alto Neuroscience (NYSE: ANRO) to $41.00 (from $22.00) while maintaining a Outperform rating.

No results found